Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing

Part of paid clinical trials in Columbus, Ohio.

Sponsor
Ohio State University Comprehensive Cancer Center
Study ID
NCT02090530
Status
Recruiting
Apply to this trial

Conditions

  • Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Biospecimen collection — OTHER
    Specimens to be collected include a fresh tumor biopsy, previously obtained tumor specimens or blocks (if available), whole blood, serum, plasma and buccal smear.

Study Details

Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing

Key Dates

Start date
Nov 4, 2013
Status verified
Apr 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Advanced Cancer Patients
    Individuals with advanced or refractory cancer must be identified by study personnel or their treating physician, deemed eligible for this study, and voluntarily agree to be enrolled in this protocol through an informed consent. Biospecimen collection includes a fresh tumor biopsy, previously obtained tumor specimens or blocks (if available), whole blood, serum, plasma and buccal smear.

Primary Outcome Measure

Number of participants receiving new therapy based on study findings [ Time Frame: Up to 24 Months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Ohio State University Wexner Medical CenterColumbusOhio43210
Sameek Roychowdhury, MD, PhD
[email protected]
614-685-5842
Sameek Roychowdhury, MD, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Columbus, OH

By research site
Ohio State University Wexner Medical Center· Columbus, OH

Related Studies